Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Allogene Therapeutics Inc...

    NASDAQ: ALLO · Real-Time Price · USD
    1.10
    0.03 (2.80%)
    At close: Aug 15, 2025, 3:47 PM

    Allogene Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 22K 95K 156K 114.09M
    Cost of Revenue
    		 n/a 14.2M 14.29M 10.45M
    Gross Profit
    		 22K 95K -14.14M 103.64M
    Operating Income
    		 -273.2M -327.74M -335.54M -180.19M
    Interest Income
    		 20.15M 18.31M 4.57M 1.71M
    Pretax Income
    		 -257.15M -327.26M -340.41M -182.05M
    Net Income
    		 -257.59M -327.26M -340.41M -182.05M
    Selling & General & Admin
    		 65.2M 71.67M 79.31M 74.11M
    Research & Development
    		 192.3M 242.91M 256.39M 220.18M
    Other Expenses
    		 15.72M 13.24M -14.29M -10.45M
    Operating Expenses
    		 273.22M 327.83M 321.4M 283.83M
    Interest Expense
    		 181K n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 273.22M 327.83M 335.69M 294.28M
    Income Tax Expense
    		 443K n/a n/a n/a
    Shares Outstanding (Basic)
    		 194.81M 156.93M 143.15M 135.82M
    Shares Outstanding (Diluted)
    		 194.81M 156.93M 143.15M 135.82M
    EPS (Basic)
    		 -1.32 -2.09 -2.38 -1.34
    EPS (Diluted)
    		 -1.32 -2.09 -2.38 -1.34
    EBITDA
    		 -243.33M -313.07M -321.24M -169.74M
    EBIT
    		 -256.97M -327.26M -335.54M -180.19M
    Depreciation & Amortization
    		 13.64M 14.2M 14.29M 10.45M

    Add to Watchlist